Patent · US Active

Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures

US8647877B2 · kind B2 · utility

0Cited by
21References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2010
Grant dateFeb 11, 2014
Priority date
Expiry dateJan 14, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/101666
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provides a nucleated red blood cell simulating particle, which may be leukocytes bound to a fluorescent-staining inhibitor capable of stably binding to the nucleus or a nucleic acid in a cell so as to reduce the binding capacity of the particles to a fluorescent dye during their detection. The present disclosure also provides a method for preparing nucleated red blood cell simulating particles, including the following steps: (a) obtaining purified leukocytes; (b) suspending the leukocytes in a cell treatment solution containing a fluorescent-staining inhibitor which stably binds to the nucleus or a nucleic acid in a cell, and (c) washing the obtained product. The present disclosure also provides a hematology control mixture containing the nucleated red blood cell simulating particles. In addition, the present disclosure describes the use of the nucleated red blood cell simulating particles and the hematology control mixtures comprising the same, for the quality control of a blood cell analyzer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.